ABI-H3733 Liquid Oral Dosage Form
ABI-H3733-101
Phase 1 small_molecule completed
Quick answer
ABI-H3733 Liquid Oral Dosage Form for Chronic Hepatitis B is a Phase 1 program (small_molecule) at ASSEMBLY BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ASSEMBLY BIOSCIENCES, INC.
- Indication
- Chronic Hepatitis B
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed